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Introduction
p-Chlorobenzaldehyde (p-CBA) is an organic compound 
comprising of benzene ring with formyl and chlorine substituents 
at 1 and 4 positions, respectively. The p-CBA is used as an 
important reaction intermediate for the manufacturing of several 
pharmaceutical drugs and agricultural chemicals [1]. It is used in 
the production of triphenyl methane and related dyes. It is also 
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Abstract
p-Chlorobenzaldehyde (p-CBA) is used as an important chemical intermediate 
for the preparation of pharmaceuticals, agricultural chemicals, dyestuffs, optical 
brighteners, and metal finishing products. The study aimed to evaluate the 
effect of biofield energy treatment on the physicochemical and spectroscopic 
properties of p-CBA. The study was accomplished in two groups i.e. control and 
treated. The control group was remained as untreated, while the treated group 
was subjected to Mr. Trivedi’s biofield energy treatment. Finally, both the samples 
(control and treated) were evaluated using various analytical techniques. The 
surface area analysis showed a substantial increase in the surface area by 23.06% 
after biofield treatment with respect to the control sample. The XRD analysis 
showed the crystalline nature of both control and treated samples. The X-ray 
diffractogram showed the significant alteration in the peak intensity in treated 
sample as compared to the control. The XRD analysis showed the slight increase 
(2.31%) in the crystallite size of treated sample as compared to the control. The 
TGA analysis exhibited the decrease (10%) in onset temperature of thermal 
degradation form 140°C (control) to 126°C in treated sample. The T
max
 (maximum 
thermal degradation temperature) was slightly decreased (2.14%) from 157.09°C 
(control) to 153.73°C in treated sample of p-CBA. This decrease in T
max
 was possibly 
due to early phase of vaporization in treated sample as compared to the control. 
The FT-IR spectrum of treated p-CBA showed the increase in wavenumber of C=C 
stretching as compared to the control. The UV spectroscopic study showed the 
similar pattern of wavelength in control and treated samples.
Altogether, the surface area, XRD, TGA-DTG and FT-IR analysis suggest that Mr. 
Trivedi’s biofield energy treatment has the impact to alter the physicochemical 
properties of p-CBA. This treated p-CBA could be utilized as a better chemical 
intermediate than the control p-CBA for the synthesis of pharmaceutical drugs 
and organic chemicals.
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used for optical brighteners and metal finishing products [1,2]. 
The p-CBA is commercially produced by side-chain chlorination 
of p-CBA followed by acid hydrolysis [3]. The p-CBA along with 
p-chloroaniline is used for the synthesis of Schiff base. The Schiff 
bases are versatile imine (C=N) containing compounds having 
broad spectrum of biological activities [4]. The incorporation 
of metals in Schiff base in the form of metal complexes 
exhibited some degree of biological activities like antifungal [5], 
antibacterial [6], anticancer [7], and anti-inflammatory activity 
[8]. As p-CBA used as an important reaction intermediate, its rate 
of reaction plays a crucial role. The literature suggests that any 
alteration in crystallite size and surface area can affect the kinetics 
of reaction [9]. Moreover, the thermal properties i.e. vaporization 
temperature, decomposition temperature of chemical compound 
also affect the reaction kinetics [10]. Therefore, considering the 
importance of p-CBA, it is important to discover an alternate and 
safe approach, which can improve the overall physicochemical 
properties of compound. Recently, biofield energy treatment has 
been reported to alter the physicochemical as well as spectral 
properties of various organic compounds and pharmaceutical 
drugs [11-13]. 
The National Institute of Health/National Center for 
Complementary and Alternative Medicine (NIH/NCCAM) 
conceived the healing energy (putative energy fields) treatment 
under the subcategory of energy therapies [14]. It is reported that 
human body is permeated and surrounded with the bioenergetic 
field (subtle energy field) [15]. The health of living organism 
depends on the balance of this bioenergetics field. In the diseased 
situation, this bioenergetics field gets depleted [16]. The experts 
of energy medicine manipulate and balance this bioenergetics 
field via harnessing the energy from the Universe [17]. Thus, the 
human (expert of energy medicine) has the ability to harness the 
energy from the Universe and transfer it to any living or nonliving 
object to balance or re-pattern the electromagnetic energy field 
[18]. The objects always receive this energy and respond in the 
useful way [19]. The biofield energy therapy is being practiced 
in the form of healing therapy or therapeutic touch throughout 
the world and especially in the western countries [20,21]. It is 
estimated that about 36% of Americans regularly uses some 
form of Complementary and Alternative Medicine (CAM) [22]. 
The biofield energy treatment is effectively used to stimulate the 
overall health of human being by reducing the pain and anxiety 
[23,24]. 
Mr. Trivedi is well known for his unique biofield energy treatment 
(The Trivedi Effect®) that has been evaluated in numerous arenas 
like agricultural research [25], biotechnology research [26], 
microbiology research [27,28], pharmaceutical sciences [13,19], 
and materials science [29,30]. 
Hence, based on the prominent impact of biofield energy 
treatment and significance of p-CBA as a chemical intermediate, 
the present study was aimed to evaluate the effect of Mr. 
Trivedi’s biofield energy treatment on the physicochemical 
and spectroscopic properties of p-CBA. The analysis was 
done using surface area analyzer, X-ray diffractometry (XRD), 
thermogravimetric analysis-derivative thermogravimetry (TGA-
DTG), Fourier transform infrared (FT-IR) spectroscopy, and UV-Vis 
spectrometry.
Materials and Methods
Study design
The p-chlorobenzaldehyde (p-CBA) was purchased from Loba 
Chemie Pvt. Ltd., India. The p-CBA was divided into two groups 
i.e. control and treated. The control sample was kept without 
treatment, while the treated sample in sealed pack was handed 
over to Mr. Trivedi to render the biofield energy treatment under 
laboratory conditions. Mr. Trivedi provided the biofield energy 
treatment to the treated group via his unique energy transmission 
process without touching the sample [13]. Afterward, both 
the control and treated samples were analyzed with respect 
to physicochemical and spectroscopic properties using various 
techniques like surface area analyzer, XRD, TGA-DTG, FT-IR and 
UV-vis spectroscopy. 
Surface area analysis 
The surface area of control and treated p-CBA was analyzed using 
the Brunauer–Emmett–Teller (BET) surface area analyzer (Smart 
SORB 90) based on the ASTM D 5604 method. The range of the 
instrument was 0.2 m2/g to 1000 m2/g. The percent change in 
surface area was calculated with the help of following equation:
[ ]Treated Control
Control
S S 
% change in surface area 100
S 
−
= ×
Here, S Control is the surface area of the control sample and S Treated is 
the surface area of treated sample.
XRD study
The XRD analysis of p-CBA (control and treated) samples was 
done on Phillips (Holland PW 1710) X-ray diffractometer with 
copper anode and nickel filter. The wavelength of XRD system 
was set to 1.54056 Å. The percent change in average crystallite 
size (G) was calculated using following equation: 
G=[(Gt-Gc)/Gc] × 100 
Here, Gc and Gt are average crystallite size of control and treated 
powder samples, respectively. 
TGA-DTG analysis 
The TGA-DTG analysis was carried out on Mettler Toledo 
simultaneous TGA-DTG analyzer. The analytes were heated up 
to 400°C from room temperature at the heating rate of 5°C/
min under air atmosphere. The onset temperature of thermal 
degradation and T
max 
(temperature at which maximum weight 
loss occur) in samples were obtained from TGA-DTG thermogram. 
Spectroscopic studies
The treated sample of p-CBA was divided into two groups i.e. T1 
and T2 for the FT-IR and UV-vis spectroscopy. The spectral data of 
treated samples were compared with the respective spectral data 
of control sample. 
FT-IR spectroscopic characterization
The FT-IR spectroscopy was done to determine the effect of 
biofield energy treatment on dipole moment, force constant, and 
bond strength in chemical structure [31]. The samples for FT-IR 
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analysis were prepared by crushing with spectroscopic grade 
KBr into fine powder. Subsequently, the mixture was pressed 
into pellets. The spectra were obtained from Shimadzu’s Fourier 
transform infrared spectrometer (Japan) with the frequency 
range of 500-4000 cm-1. 
UV-Vis spectroscopic analysis
The UV spectra of control and treated samples of p-CBA were 
obtained from Shimadzu UV spectrometer (2400 PC) with quartz 
cell of 1 cm and a slit width of 2.0 nm. The analysis was done at 
the wavelength range of 200-400 nm. 
Results and Discussion
Surface area analysis
The surface area of control and treated p-CBA are shown in 
Figure 1. The surface area of control and treated sample were 
found as 0.2498 m2/g and 0.3074 m2/g, respectively. The result 
showed an increase in surface area by 23.06% in the treated 
sample with respect to the control sample. It is well known 
that surface area is inversely proportional to the particle size 
[32]. Based on this, it is presumed that biofield energy induced 
the milling process, which leads to decrease the particle size of 
treated sample. As a result, the surface area of treated sample 
was increased significantly. 
XRD analysis 
The XRD diffractograms of p-CBA (control and treated) samples 
are shown in Figure 2. The XRD diffractograms of both samples 
showed the sharp and intense peaks that suggest the crystalline 
nature of control and treated samples. The XRD diffractogram 
of control sample showed the peaks at 2θ equal to 13.6°, 16.8°, 
17.09°, 18.85°, 19.06°, 21.48°, 26.86°, 27.45°, 41.01°, and 42.91°. 
Similarly, the XRD diffractogram of treated p-CBA exhibited the 
XRD peaks at 2θ equal to 13.73°, 14.98°, 16.71°, 19.19°, 27.26°, 
29.38°, 30.61°, 40.81°, 42.35°, and 47.77°. The Figure 2 showed 
the significant alteration in the intensity of XRD peaks intensity 
after biofield treatment as compared to the control sample. The 
most intense peak in control sample was observed at 19.06°; 
while in treated sample the most intense peak was observed 
at 29.38°. The literature suggests that alteration in crystal 
morphology may lead to alteration in relative intensities of the 
peaks [33]. Additionally, it is reported that internal strain can also 
change the 2θ values [34]. Based on this, it is hypothesized that 
biofield energy treatment was induced an internal strain in the 
treated sample that might be responsible for the alteration in its 
2θ values with respect to the control sample. 
The average crystallite size of the control sample was calculated 
as 154.52 nm, while the crystallite size of treated sample was 
calculated as 158.09 nm. The result depicted a slight increase 
(2.31%) in the crystallite size of treated sample with respect to 
the control (Figure 3). It is previously reported that increase in 
annealing temperature expressively affects the crystallite size 
of the compounds. The increase in temperature might lead to 
decrease in dislocation density and increase in the number of unit 
cell; these finally increases the average crystallite size of sample 
[35,36]. Based on this, it is assumed that biofield treatment might 
provide some thermal energy to p-CBA molecules. Consequently, 
the dislocation density might be reduced and thus the number 
of unit cells and average crystallite size were increased in the 
treated sample. 
TGA-DTG analysis
The TGA-DTG thermogram of p-CBA samples (control and treated) 
are shown in Figure 4 and data are presented in (Table 1). The TGA 
thermogram of control sample showed an initiation (on-set) of 
thermal degradation at 140°C, which was ended (end-set) at 
Figure 1 Surface area analysis of control and treated 
p-chlorobenzaldehyde. Figure 2 XRD diffractogram of p-chlorobenzaldehyde.
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183°C. Similarly, the TGA thermogram of the treated sample 
exhibited the on-set temperature at 126°C that was terminated 
(end-set) at 185.5°C. The result showed about 10% decrease 
in the onset temperature in biofield energy treated sample 
as compared to the control. The TGA-DTG study showed the 
decrease in thermal stability of treated sample with respect to 
the control that could be correlated to increase in the chemical 
reactivity of p-CBA. Moreover, the percentage weight loss during 
the thermal decomposition was found as 51.25% in the control, 
while 52.18% in the treated sample. The result showed a mere 
increase in percent weight loss during thermal decomposition of 
treated sample with respect to the control. Moreover, the DTG 
thermogram exhibited the T
max
 (temperature at which the sample 
lost its maximum weight) at 157.09°C in the control sample and at 
153.73°C in the treated sample. The result showed about 2.14% 
decrease in T
max 
of treated sample as compared to the control. 
This might occur due to the changes in internal energy via biofield 
energy treatment, which may cause to early phase of evaporation 
in treated sample with respect to the control [37]. 
FT-IR spectroscopic analysis
FT-IR spectra of the control and treated p-CBA are shown in 
Figure 5. The p-CBA molecule contains =C-H, C=C, C-C, C=O, 
C-Cl groups of vibrations. The =C-H (aromatic) stretching was 
attributed to peaks at 3088 cm-1 in control and treated (T1 and 
T2) samples. While, the aldehyde C-H stretching was assigned 
to peak appeared at 2860 cm-1 in all the control and treated 
samples. The aldehyde C-H asymmetrical bending was attributed 
to peak at 1485 cm-1 in all the three samples (control, T1 and T2). 
Moreover, the aldehyde C-H symmetrical bending was attributed 
to peaks observed at 1386 cm-1 in control and T1 sample and 1384 
cm-1 in T2 sample. The out of plane ring deformation was assigned 
Figure 3 Average crystallite size of control and treated 
p-chlorobenzaldehyde.
Figure 4 TGA-DTG thermogram of control and treated 
p-chlorobenzaldehyde.
 
Figure 5 FT-IR spectra of control and treated (T1 and T2) 
p-chlorobenzaldehyde.
Table 1 Thermal analysis of control and treated samples of 
p-chlorobenzaldehyde. T
max
: Temperature at maximum weight loss 
occurs.
Parameter Control Treated
Onset temperature (°C) 140.00 126.00
End-set temperature (°C) 183.00 185.50
T
max
 (°C) 157.09 153.73
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to the control. The TGA-DTG study showed the slight decrease 
(10.0%) in onset temperature of thermal degradation with 
respect to the control. The decrease in thermal stability might be 
correlated to increase in chemical reactivity of p-CBA. The FT-IR 
data showed the upstream shifting of C=C stretching frequencies 
with respect to the control. This might be due to the increase in 
force constant and bond strength of C=C group in treated p-CBA 
molecule as compared to the control. 
Overall, the present study concluded the substantial impact of 
Mr. Trivedi’s biofield energy treatment on physicochemical and 
spectroscopic properties of p-CBA. Based on this, it is anticipated 
that Mr. Trivedi’s unique biofield energy treatment can effectively 
transform the physicochemical properties of p-CBA into the 
more useful form so that it could be utilized as a better chemical 
intermediate for the synthesis of pharmaceutical drugs and 
organic chemicals. 
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to peaks at 1093-1207 cm-1 region of spectra in all three samples; 
whereas, the in-plane deformation was assigned to peaks in the 
range of 702-839 cm-1 (control), 704-839 cm-1 (T1), and 704-837 
cm-1 (T2) sample. 
The C=C (aromatic) stretching was assigned to peaks appeared at 
1575-1589 cm-1 in control and T1 samples, while it was appeared 
at 1577-1597 cm-1 in T2 sample. Similarly, the C-C stretching was 
assigned to peaks at 1292 cm-1 in control and T1 samples, while 
it was observed at 1294 cm-1 in T2 sample. The C=O stretching 
peak was assigned to peaks at 1699 cm-1 in control sample and 
1701 cm-1 in the treated samples. In addition, the C-O and C-Cl 
stretching were appeared at 1012 cm-1 and 542 cm-1, respectively 
in all the three samples (control, T1 and T2). 
The result showed a slight increase in the frequency of C=C 
stretching in T2 sample as compared to the control. This is might 
be due to increased bond strength of C=C group in treated p-CBA 
molecules as compared to the control. The stretching frequency 
of any bond depends on the dipole moment (µ) and reduced 
mass (m) [38,39]. Therefore, it is presumed that biofield energy 
treatment might increase the dipole moment of C=C bond as 
compared to the control sample. Except this, rest of the IR 
vibration peaks were appeared at the similar frequency region in 
all three samples. 
UV-Vis spectroscopy 
UV spectra of the control and treated p-CBA are shown 
in Figure 6. The UV spectrum of control sample showed the 
absorbance maxima (λ
max
) at 206.6 and 254.4 nm. Similarly, 
the UV spectra of treated sample showed the λ
max
 at 206.8 and 
254.6 nm in T1 and 207.5 and 254.0 nm in T2 sample. The result 
showed the similar pattern of absorbance maxima in the control 
and treated samples. 
The compound absorbs UV waves due to transition of electrons 
from highest occupied molecular orbital (HOMO) to highest 
unoccupied molecular orbital (LUMO). When the energy gap 
between HOMO and LUMO (also called as HOMO-LUMO gap) 
altered, the wavelength (λ
max
) was also altered [31]. However, 
the UV study of p-CBA showed the similar pattern of absorbance 
maxima in both the control and treated samples. Therefore, it 
can be concluded that the biofield treatment did not distract 
the energy gap between HOMO-LUMO in treated sample, as 
compared to the control sample. 
Conclusions
In conclusion, the present study showed the substantial increase 
in surface area of treated sample by 23.06% as compared to the 
control sample. The XRD study showed the crystalline nature of 
both control and treated sample. Moreover, the intensity of XRD 
peaks were also altered after biofield treatment as compared 
Figure 6 UV spectra of control and treated (T1 and T2) 
p-chlorobenzaldehyde.
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